161 related articles for article (PubMed ID: 10798768)
1. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival.
O'Rourke RW; Kang SM; Lower JA; Feng S; Ascher NL; Baekkeskov S; Stock PG
Transplantation; 2000 Apr; 69(7):1440-6. PubMed ID: 10798768
[TBL] [Abstract][Full Text] [Related]
2. CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.
Yang DF; Qiu WH; Zhu HF; Lei P; Wen X; Dai H; Zhou W; Shen GX
Transpl Immunol; 2008 Jul; 19(3-4):197-201. PubMed ID: 18667318
[TBL] [Abstract][Full Text] [Related]
3. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival.
Gainer AL; Korbutt GS; Rajotte RV; Warnock GL; Elliott JF
Transplantation; 1997 Apr; 63(7):1017-21. PubMed ID: 9112357
[TBL] [Abstract][Full Text] [Related]
4. Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand.
Gainer AL; Suarez-Pinzon WL; Min WP; Swiston JR; Hancock-Friesen C; Korbutt GS; Rajotte RV; Warnock GL; Elliott JF
Transplantation; 1998 Jul; 66(2):194-9. PubMed ID: 9701263
[TBL] [Abstract][Full Text] [Related]
5. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.
Kimura F; Gotoh M; Tanaka T; Luo Z; Miyazaki J; Uede T; Monden M; Miyasaka M
Diabetologia; 2002 Jun; 45(6):831-40. PubMed ID: 12107727
[TBL] [Abstract][Full Text] [Related]
6. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of allograft survival of transfected islets expressing human CTLA4-Ig, human soluble Fas ligand or a combination of the two.
Gainer AL; Suarez-Pinzon WL; Min WP; Hancock-Friesen C; Korbutt GS; Rajotte RV; Rabinovitch A; Warnock GL; Elliott JF
Transplant Proc; 1998 Mar; 30(2):534. PubMed ID: 9532165
[No Abstract] [Full Text] [Related]
8. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
10. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection.
Ferrari-Lacraz S; Zheng XX; Kim YS; Li Y; Maslinski W; Li XC; Strom TB
J Immunol; 2001 Sep; 167(6):3478-85. PubMed ID: 11544341
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of corneal allograft reaction by CTLA4-Ig.
Hoffmann F; Zhang EP; Pohl T; Kunzendorf U; Wachtlin J; Bulfone-Paus S
Graefes Arch Clin Exp Ophthalmol; 1997 Aug; 235(8):535-40. PubMed ID: 9285225
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.
Fernandes JR; Duvivier-Kali VF; Keegan M; Hollister-Lock J; Omer A; Su S; Bonner-Weir S; Feng S; Lee JS; Mulligan RC; Weir GC
Transpl Immunol; 2004 Nov; 13(3):191-200. PubMed ID: 15381202
[TBL] [Abstract][Full Text] [Related]
13. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig.
Feng S; Quickel RR; Hollister-Lock J; McLeod M; Bonner-Weir S; Mulligan RC; Weir GC
Transplantation; 1999 Jun; 67(12):1607-13. PubMed ID: 10401769
[TBL] [Abstract][Full Text] [Related]
14. Protection of corneal allografts by CTLA4-Ig.
Gebhardt BM; Hodkin M; Varnell ED; Kaufman HE
Cornea; 1999 May; 18(3):314-20. PubMed ID: 10336035
[TBL] [Abstract][Full Text] [Related]
15. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
[TBL] [Abstract][Full Text] [Related]
16. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4-Ig regulates tryptophan catabolism in vivo.
Grohmann U; Orabona C; Fallarino F; Vacca C; Calcinaro F; Falorni A; Candeloro P; Belladonna ML; Bianchi R; Fioretti MC; Puccetti P
Nat Immunol; 2002 Nov; 3(11):1097-101. PubMed ID: 12368911
[TBL] [Abstract][Full Text] [Related]
18. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
19. Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation.
König Merediz SA; Zhang EP; Wittig B; Hoffmann F
Graefes Arch Clin Exp Ophthalmol; 2000 Aug; 238(8):701-7. PubMed ID: 11011692
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.
Steurer W; Nickerson PW; Steele AW; Steiger J; Zheng XX; Strom TB
J Immunol; 1995 Aug; 155(3):1165-74. PubMed ID: 7543517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
